A lymph node ratio of 10% is predictive of survival in stage III colon cancer: a French regional study.

@article{Sabbagh2014ALN,
  title={A lymph node ratio of 10% is predictive of survival in stage III colon cancer: a French regional study.},
  author={Charles Sabbagh and François Mauvais and Cyril Coss{\'e} and Lionel Rebibo and Jean-paul Joly and Didier Dromer and Christine Aubert and Sophie Carton and Bernard Dron and Innocenti Dadamessi and Bernard Maes and Guillaume Perrier and David Manaouil and Jean-François Fontaine and Michel Gozy and Xavier Panis and Pierre Henri Foncelle and Hugues de Fresnoy and Fabien Leroux and Pierre Vaneslander and Caroline Ghighi and Jean-Marc Regimbeau},
  journal={International surgery},
  year={2014},
  volume={99 4},
  pages={
          344-53
        }
}
Lymph node ratio (LNR) (positive lymph nodes/sampled lymph nodes) is predictive of survival in colon cancer. The aim of the present study was to validate the LNR as a prognostic factor and to determine the optimum LNR cutoff for distinguishing between "good prognosis" and "poor prognosis" colon cancer patients. From January 2003 to December 2007, patients with TNM stage III colon cancer operated on with at least of 3 years of follow-up and not lost to follow-up were included in this… CONTINUE READING
BETA
1
Twitter Mention

Similar Papers

References

Publications referenced by this paper.
SHOWING 1-10 OF 22 REFERENCES

Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer.

  • The New England journal of medicine
  • 2004
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL

[Digestive oncology: surgical practices].

  • Journal de chirurgie
  • 2009
VIEW 2 EXCERPTS